Ginkgo Bioworks Holdings Ratios (2019-2025) | DNA

Ratios Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
-68.13%-88.19%-32.45%-21.74%28.34%16.33%-120.93%0.56%-144.25%-113.83%100.00%100.00%100.00%78.99%88.78%108.96%91.54%89.15%78.95%55.68%
EBT Margin (Quarter)
-169.94%-125.80%-132.21%-1,081.31%-351.99%-463.71%-1,009.31%-191.13%-253.88%-215.03%-546.48%-609.67%-437.17%-386.06%-63.76%-245.99%-188.06%-122.13%-207.93%-243.72%
EBIT Margin (Quarter)
-129.52%-137.38%-34.37%-1,134.55%-401.04%-447.92%-986.38%-234.89%-267.34%-228.57%-516.68%-512.49%-469.12%-396.66%-61.99%-236.29%-184.13%-132.13%-231.78%-211.86%
EBITDA Margin (Quarter)
-129.52%-137.38%-34.37%-1,134.55%-401.04%-447.92%-1,012.90%-170.73%-252.72%-214.73%-549.32%-596.49%-445.25%-386.71%-61.11%-249.97%-186.27%-116.52%-207.05%-242.23%
Operating Margin (Quarter)
-129.52%-137.38%-34.37%-1,134.55%-401.04%-447.92%-986.38%-234.89%-267.34%-228.57%-516.68%-512.49%-469.12%-396.66%-61.99%-236.29%-184.13%-132.13%-231.78%-211.86%
Net Margin (Quarter)
-169.58%-124.81%-131.95%-1,080.85%-350.65%-463.68%-1,009.26%-176.10%-253.98%-215.12%-546.44%-609.10%-437.25%-386.40%-63.34%-245.25%-188.25%-121.56%-207.93%-241.80%
FCF Margin (Quarter)
-158.89%-135.08%-13.75%-114.92%-13.94%-75.36%-63.00%-132.45%-136.34%-108.07%-140.60%-176.31%-252.92%-198.24%-133.18%-128.05%-122.40%-81.23%-81.38%-142.78%
Efficiency
Inventory Average (Quarter)
3.42M6.03M8.40M6.98M5.11M3.44M1.45M0.23M
Assets Average (Quarter)
1,201.59M1,727.01M1,938.29M2,110.79M2,064.36M2,025.97M1,932.46M2,205.01M2,478.26M2,354.60M2,159.20M1,845.87M1,623.55M1,603.51M1,553.07M1,429.17M1,335.46M1,262.24M1,210.09M1,154.43M
Equity Average (Quarter)
432.81M375.68M986.88M1,592.67M1,593.31M1,595.75M1,508.05M1,590.07M1,671.93M1,555.59M1,378.13M1,174.92M1,042.21M910.17M815.51M757.00M681.74M630.19M586.37M534.19M
Invested Capital (Quarter)
395.57M356.42M1,617.97M1,567.38M1,619.24M1,572.25M1,443.86M1,739.08M1,607.59M1,503.59M1,252.68M1,097.15M987.27M833.07M797.94M716.06M647.43M612.95M559.78M508.59M
Asset Utilization Ratio (Quarter)
0.080.100.150.210.270.270.220.160.140.150.140.130.110.140.160.180.180.150.15
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-41.10-0.00M12.8319.07-4.0521.625.97-3.30
Debt to Equity (Quarter)
0.00
Debt Ratio (Quarter)
0.00
Equity Ratio (Quarter)
0.230.210.750.760.790.790.770.680.670.660.620.660.620.510.540.520.500.500.470.45
Times Interest Earned (Quarter)
-41.10-0.00M12.8319.07-4.0521.625.97-3.30
Valuation
Enterprise Value (Quarter)
-308.13M-235.89M-1672.64M-1487.99M-1459.72M-1345.53M-1297.60M-1315.79M-1206.09M-1105.79M-1049.24M-944.07M-840.44M-730.37M-616.21M-561.57M-312.42M-203.57M-111.06M-422.62M
Return Ratios
Return on Sales (Quarter)
-0.02%-0.01%-0.01%-0.11%-0.04%-0.05%-0.10%-0.02%-0.03%-0.02%-0.05%-0.06%-0.04%-0.04%-0.01%-0.02%-0.02%-0.01%-0.02%-0.02%
Return on Capital Employed (Quarter)
-12.04%-10.80%-92.53%-128.43%-160.48%-202.63%-108.71%-76.50%-58.67%-46.07%-51.39%-56.83%-60.21%-44.09%-42.34%-38.59%-26.88%-31.80%-29.79%
Return on Invested Capital (Quarter)
-0.01%0.00%-0.01%-0.02%-0.02%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%-0.01%
Return on Assets (Quarter)
0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%-0.01%0.00%0.00%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%-0.01%0.00%-0.01%-0.01%-0.02%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%